| Authors: |
Boer J; Incyte Corporation, 1801 Augustine Cut-Off, Wilmington, Delaware, USA., Cannady E; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana, USA., Cuyckens F; Johnson & Johnson, Turnhoutseweg, 30, Beerse, Belgium., Glaenzel U; PK Sciences, Novartis Pharma AG, Fabrikstrasse 14, WSJ-153 1.02, Basel, 4056, Switzerland., Granvil C; Work supported at Gilead Sciences, Foster City, California, USA., Huth F; PK Sciences, Novartis Pharma AG, 4056, Basel, Switzerland., James AD; PK Sciences, Novartis Pharma AG, Fabrikstrasse 14, WSJ-153 1.02, Basel, 4056, Switzerland., Li W; Work Supported at Bristol-Myers Squibb, Princeton, New Jersey, USA., Veau C; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Young G; GlaxoSmithKline Research & Development Ltd., David Jack Centre, Ware, UK., Yue Q; Work supported at Gilead Sciences, Foster City, California, USA., Walker GS; Pfizer, Groton, Connecticut, USA., Argikar UA; Gates Medical Research Institute, Cambridge, Massachusetts, USA., Bauman JN; Pfizer, Groton, Connecticut, USA., Cantalloube C; Sanofi, Vitry sur Seine, France., Chen YL; Sumitomo Pharma America, Marlborough, Massachusetts, USA., Kang P; Vertex Pharmaceuticals, San Diego, California, USA., Moliner P; Sanofi, Montpellier, France., Pedersen ML; Drug Metabolism and Pharmacokinetics, Early Research and Development, Cardiovascular, Renal and Metabolism, Biopharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden., Piel I; Bayer AG, Wuppertal, Germany., Schadt S; Roche Pharma Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, F. Hoffmann-La Roche, Basel, Switzerland., Schieferstein H; The Healthcare Business of Merck KGaA, Darmstadt, Germany., Suchomel J; 1 DNA Way, MS 412a, DMPK, Genentech, Inc., South San Francisco, California, USA., Wang S; 1 DNA Way, MS 412a, DMPK, Genentech, Inc., South San Francisco, California, USA., Khojasteh SC; 1 DNA Way, MS 412a, DMPK, Genentech, Inc., South San Francisco, California, USA. |
